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Commentators have suggested that patients
may understand quantitative information about treatment
benefits better when they are presented as numbers needed to




To determine whether NNT helps patients
interpret treatment benefits better than absolute risk reduc-
tion (ARR), relative risk reduction (RRR), or a combination of












Three hundred fifty-seven men and women, ages




Subjects were given written information about
the baseline risk of a hypothetical “disease Y” and were asked
(1) to compare the benefits of two drug treatments for disease Y,
stating which provided more benefit; and (2) to calculate the
effect of one of those drug treatments on a given baseline risk of
disease. Risk information was presented to each subject in one of




When asked to state which of two treatments
provided more benefit, subjects who received the RRR format
responded correctly most often (60% correct vs 43% for COMBO,




 = .001). Most subjects were
unable to calculate the effect of drug treatment on the given
baseline risk of disease, although subjects receiving the RRR
and ARR formats responded correctly more often (21% and








Patients are best able to interpret the benefits
of treatment when they are presented in an RRR format with
a given baseline risk of disease. ARR also is easily interpreted.
NNT is often misinterpreted by patients and should not be used




data interpretation (statistical); decision making;
numeracy; patient participation (statistics and numerical data).
 




n a recent report, the Institute of Medicine recognized
“patient centeredness” as a key component of health care
quality, stating that a provider-patient partnership is needed
“to ensure that decisions respect patients’ wants, needs,
and preferences and that patients have the education and





 With this emphasis on involving patients
in decision making, clinicians are increasingly challenged
to communicate health information to patients in unbiased
and easily understandable ways. This is especially true
for decisions in which the balance of potential harms and
benefits is a close call. In those decisions, patients must
understand quantitative information to compare the poten-
tial harms and benefits and choose the health alternative
that is most consistent with their values. For clinicians, this
raises questions about how to communicate a clear picture
of the harms and benefits associated with each decision.
For communicating treatment benefits, some have
suggested that quantitative information may be best inter-





 Number needed to treat is an empirically derived
estimate of the number of patients who must be treated
in order to expect that one patient will avoid an adverse
event or outcome over a defined period of time. Mathemat-
ically, NNT is the reciprocal of the absolute risk reduction
(ARR: the decrease in disease incidence due to treatment),
and therefore provides an estimate of absolute patient
benefit. Enthusiasm for its use arose because of its





 and because of patients’ difficulties in










 and its name, which encourages individuals to




Studies examining the effects of presenting treatment
benefit information to patients in alternate risk reduction
formats have examined the persuasiveness of NNT, not a





pared the willingness of patients to accept a treatment whose
benefits were presented alternately as NNT, ARR, or relative
risk reduction (RRR: the decrease in disease incidence rela-
tive to those who are not taking treatment). They found
that patients were more willing to accept a treatment when
benefits were presented as an RRR rather than as an ARR
or an NNT. Such studies may indicate that NNT is less per-
suasive to patients than other presentations of treatment
benefits. These studies, however, did not examine a patient’s
ability to correctly interpret the information they received;
willingness to accept treatment is dependent on patient
values, not solely on correct interpretation of information
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on treatment benefits. At present, we know of no empiric
evidence about whether patients understand information
on treatment benefits better when they are presented as
NNT compared to other common risk formats.
Our study examined whether patients better under-
stand written information on treatment benefits when it is
presented as NNT, ARR, RRR or COMBO. Because under-
standing is a complex process that is not easily measured,
we used patient ability to correctly interpret information






After approval from our university institutional review
board, we surveyed men and women, ages 50 to 80, who pre-
sented for care at a university internal medicine clinic.
Patients were excluded if this was their first visit to the
clinic, if they reported that they were unable to understand,
speak, or read English, or if they had previously participated
in the survey. Potential participants were identified from
daily clinician schedules and were approached about the
study in the clinic waiting room or in their exam room while
they waited for the clinician. When our research assistant
was not interviewing other study patients, she approached
every next eligible and available patient who was between
the ages of 50 and 80 and presented to our clinic for a return
visit. Overall, we estimate that she approached 60% of pati-
ents ages 50 to 80 who presented to our clinic for a return




Presentation of Information on Treatment Benefit.
 
Written in-
formation about the baseline risk of a hypothetical disease Y
and the benefits of two hypothetical treatments was presented
to each subject in one of four risk reduction formats: NNT,
ARR, RRR, or a combination of all three of these formats (see
Fig. 1). Questionnaires differed only in this risk presentation.
 
Assessment of Ability to Interpret Treatment Benefit.
 
Subjects
were given information about the baseline risk of a hypo-
thetical disease Y and were asked (1) to state which of two
drug treatments for disease Y provided more benefit, and (2)
to calculate the effect of one of these drug treatments on the
given baseline risk of disease:
(1) Compare treatments A and B. Which treatment is more
effective?
1. Don’t know
2. A is more effective than B
3. B is more effective than A
4. A and B are equally effective
(2) What is the chance that you will develop disease Y after
treatment A? ___ out of 1,000
Responses to these two tasks were counted as either correct




We assessed numeracy using the





to these questions were counted as either correct or incorrect
according to the calculations that are shown.
 
Assessment of Prior Exposure to Risk Concepts.
 
To assess
patients’ familiarity with risk concepts, we measured several
indicators of prior exposure to risk concepts: education,
including statistics or epidemiology training; discussion of
a medical decision with a physician; prior quantitative risk
discussions with a physician; and self-perceived facility
with numbers.
 
Assessment of Demographic Information.
 
The demographic
characteristics of each study participant were assessed
with single-item questions on age, race/ethnicity, education,




We used a computerized random number generator
to assign risk presentation formats to each consecutively
recruited subject. Format assignments were sealed in secu-
rity envelopes until just prior to questionnaire administra-
tion. After a subject agreed to participate in the survey, the
research assistant broke the seal on the security envelope,
determined the assignment, and gave the subject the appro-




Questionnaires were self-administered and took appro-
ximately 10 minutes to complete. We did not allow subjects
to ask the research assistant for clarification on any ques-
tions; we did, however, perform cognitive and pilot testing
of the questionnaire on both first-year medical students
and patients prior to survey administration to minimize
unanswered questions due to survey burden or confusion
over question wording.
We collected all questionnaires before subjects left the
clinic. Questionnaires were counted as complete and were
included in the analysis if they had any marks on the last
two pages, which included three questions on numeracy




We determined that a sample size of 100 in each risk
reduction format group was required to detect a 15%
difference in the proportion of people correctly comparing
and calculating the effects of treatment on a given baseline
risk of disease, accepting an alpha of 0.05 and a power of
80%. We considered 15% a clinically important difference.
Additionally, a recent study had shown an approximately
15% difference in the proportion of women who were able
to correctly apply information about mammography benefits
when the information was presented alternately as ARR or
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To assess the success of randomization, we compared
the characteristics of subjects who received each risk pre-




















 tests to examine the relationships between risk reduction
format and (1) the ability to correctly assess which of two
treatment benefits provided greater benefit, and (2) the
ability to correctly calculate the effect of treatment on a
given baseline risk of disease. Fisher’s exact tests were used
when comparisons involved a small number of subjects.
The relationships between each baseline characteristic and
subject ability to correctly perceive treatment benefit was
calculated in a similar manner. Due to multiple testing, we




A total of 623 patients were approached to participate
in our survey (see Fig. 3). Fourteen percent were ineligible
and 22% refused. Three hundred ninety-eight eligible patients
returned their questionnaires for a response rate of 74%.
Ninety percent of returned questionnaires were complete
according to our criteria, and 94% of these had pen marks
indicating consideration of at least 1 of the 2 questions
regarding treatment benefit. Ninety percent had an answer
for the comparison of the benefits of 2 treatments and 65%
had an answer for the effect of treatment on a given base-
line risk of disease; in the remaining 10% and 35% of
questionnaires in which no answer was provided, the blanks
were counted as incorrect answers.
Table 1 provides information about the study partici-
pants. Subjects in the NNT group were somewhat more
likely to be male and white. Accounting for multiple com-
parisons, however, the baseline characteristics of the four
groups were statistically similar.
 
Ability to Interpret Treatment Benefit
 
Subjects correctly identified which of 2 treatments
provided greater benefit 44% of the time, but correctly
calculated the exact effect of treatment benefit on a given
risk of disease only 13% of the time. The format in which
information on treatment benefits was presented had a
strong effect on subjects’ ability to compare and calculate
treatment benefits (see Fig. 4).
When comparing 2 treatments, 30% of subjects who
received information as NNT correctly stated which treat-
ment provided more benefit compared with 60% of subjects
who received RRR, 42% who received ARR, and 43% who




 = .001). When calculating the effect
of treatment on a given baseline risk of disease, however,
only 6% of subjects who received information as NNT cor-
rectly stated which treatment provided more benefit, com-
pared with 21% who received RRR, 17% who received ARR,





In the NNT group, 39% of subjects provided no answer
when asked to calculate the exact effect of treatment on








a given baseline risk of disease, compared with 26% of
subjects in the RRR group, 32% in the ARR group, and 42%




 = .12). Of those who calculated the
exact effect of treatment on the given baseline risk of dis-
ease, 15% were off by an order of magnitude or more: 25%
in the NNT group, 11% in the RRR group, 17% in the ARR




 = .08). Interestingly,
a substantial portion of each group (25% in the NNT group,
19% in the RRR group, 38% in the ARR group, and 45%




 = .008) reported that the correct
FIGURE 3. Patient accrual.











(N = 357) P Value*
Mean age, y 63 62 62 64 63 .57
Male, % 32 35 27 48 35 .03
White, % 60 76 62 79 69 .01
Fair/poor health, % 50 49 42 56 51 .29
Discussion of medical decision with a doctor, % 56 72 59 63 62 .12
Receiving some quantitative information from a doctor, % 13 15 13 12 13 .50
With some college education, % 51 61 54 66 58 .52
With statistics training, % 16 19 17 26 20 .39
Consider themselves good with numbers, % 70 71 70 70 70 .99
Answering 3 numeracy questions correctly, % 0 2 3 3 2 .60
Answering 2 numeracy questions correctly, % 30 23 25 32 27
Answering 1 numeracy question correctly, % 27 37 27 28 30
Answering no numeracy questions correctly, % 43 38 44 37 41
* P value for any difference in patient characteristics among the 4 risk presentation format groups.









answer was “10 per 1,000,” which is the magnitude of the




Although 70% of subjects perceived themselves to be
good with numbers, only 2% of subjects answered all three
numeracy questions correctly: 28% answered 2 numeracy
questions correctly and 71% answered 1 (30%) or no (41%)
numeracy questions correctly (see Table 1). As expected, a
subject’s level of education was correlated with their
numeracy score (Pearson’s correlation coefficient = 0.55).
Nonetheless, 56% of subjects who had at least some
college education answered 1 or no numeracy questions
correctly.
 
Relationship Between Numeracy and the Ability to 
Interpret Treatment Benefit
 
Patients with better numeracy skills correctly com-
pared and calculated treatment benefits more often (see
Fig. 5). Eighty-eight percent of subjects who gave 3 correct
answers to the numeracy questions correctly stated which
treatment provided more benefit, whereas only 63% of
subjects who gave 2 correct answers to the numeracy ques-
tions, and 35% of subjects who gave 1 or no correct answers




 < .001). Sim-
ilarly, 50% of subjects who gave 3 correct answers to the
numeracy questions correctly calculated the effect of treat-
ment on a given baseline risk of disease, compared with 30%
of subjects who gave 2 correct answers to the numeracy
questions, and 5% of subjects who gave 1 or no correct






Relationship Between Subjects’ Demographics and 
the Ability to Interpret Treatment Benefit
 
Subjects’ ability to compare and calculate treatment
benefits was affected by their baseline characteristics (see
Table 2). Subjects had more difficulty with both comparisons
and calculations if they were female, nonwhite, had no
college education, were in poor health, or had no prior quan-




Although some have suggested that quantitative treat-
ment benefit information may be best interpreted when
FIGURE 4. Risk reduction format and the ability to correctly interpret treatment benefits.












 our study suggests just the oppo-
site. Patients had more difficulty interpreting written treat-
ment benefit information when it was presented as NNT.
This effect was evident whether patients were comparing the
benefits of two treatments or calculating the exact effect of
a treatment on a given baseline risk of disease. The difficulty
was magnified in patients with lower numeracy levels.
Patients’ difficulties with NNT could perhaps have been
predicted from the results of several studies examining the
perception of risk in both rate (X in 1,000) and proportion




 All of these studies found that patients
had more difficulty with the “1 in X” scale, perhaps because
larger numbers are represented by smaller numbers in
the denominator. Because NNT is essentially a “1 in X”
scale, reporting the number of people who must be treated
for 1 person to benefit, it is not surprising that patients
would have difficulty comparing and calculating treatment
benefits presented as NNT.
This study suggests that written information on treat-
ment benefits is better understood when it is presented as
ARR or RRR in the context of a given baseline risk of dis-
ease. When comparing the effectiveness of 2 treatments,
both the ARR and RRR require equivalent and straightfor-
ward tasks: the patient must choose the treatment with
the largest risk reduction. When calculating the effect of a
given treatment on a baseline risk, the ARR requires the
simplest task: subtraction. The RRR presentation, however,
requires a very familiar task, a task akin to figuring out
how much money would be saved during a sale at the store.
Familiarity may serve to smooth differences attributable to
format. The effect of the combination presentation is more
difficult to characterize. It is as easily interpretable as the
ARR and RRR presentations when patients are asked to
compare the effectiveness of 2 treatments, but performs no
better than the NNT presentation when patients are asked
to calculate the effect of a treatment on a given baseline
risk of disease. This result is harder to explain, but may
be due to overload of information or the more difficult con-
struct of the presentation format. Regardless, the poor
performance of patients presented with the combination
presentation when they are trying to calculate the effect of
treatment on a given risk of disease makes the presentation
format a less desirable one for clinicians. More information
is not necessarily better.
Because even patients who received the “simplest” risk
presentation formats had difficulty comparing and calcu-
lating treatment benefit information, this study again
raises questions about whether patients can independently
make informed medical decisions using written quantita-
tive information. We did note that patients who had a recent
medical discussion with their doctor, or who reported receiv-
ing at least some quantitative information from their doctor,
Table 2. Percentage of Subjects Correctly Comparing and Calculating Treatment Benefits, According to Their Baseline 
Characteristics (N = 357)
 
 
Characteristic N % Correct Comparison* P Value % Correct Calculation* P Value
Sex
Male 126 54 .004 24 <.001
Female 229 38 7
Race
White 245 54 <.001 18 <.001
Nonwhite 110 20 1
Education
Some college 203 56 <.001 21 <.001
No college 41 2
Health status
Fair/poor 180 36 .002 4 <.001
Good/excellent 175 52 22
Discussion of medical 
decision with an MD
Yes 223 51 <.001 17 .001
No 134 31 5
Information presentation 
by a doctor
Some quantitative 41 76 <.001 37 <.001
Qualitative 216 44 13
Consider themselves good 
with numbers
Yes 234 50 .002 17 <.001
No 99 31 3
Statistical training
Some 68 66 <.001 35 <.001
None 280 39 7








interpreted treatment benefits correctly more often than
patients who did not report these interactions. This finding
may indicate that patients who are more educated, or have
better numeracy skills, are more likely to receive quanti-
tative information from their physicians. Alternately, it may
indicate that patients can learn the skills needed to inter-
pret quantitative presentations of treatment benefits through
discussions with their doctor. We are aware of at least one
effort to prepare patients to better interpret quantitative





 Additionally, several researchers continue to
explore more accessible ways to present quantitative infor-
mation. A recent comparison of graphical and numerical
presentations of treatment benefit, however, showed that
numbers were interpreted equally well (in comparison





 Thus, a continued effort to improve patient
interpretation of numerical treatment benefits is indicated.
The Evidence-Based Medicine Working Group has
recently proposed presenting patients with the Likelihood





 This treatment benefit presen-
tation format incorporates an individual patient’s values
with the number of patients that need to be treated for a
benefit to be realized in 1 and the number of patients that
need to be treated for a harm to be realized in 1, to report that
a patient is x times more likely to be helped than harmed.
The Likelihood of Being Helped Versus Harmed format
avoids the problematic “1 in x” scale of the Number Needed
to Treat and obviates the need for a patient to calculate
the exact effect of a treatment on a given baseline risk of
disease, because the goal of this calculation is to facilitate
the weighing of harms and benefits. This presentation format
therefore deserves further testing. Until this or the other
innovations in the quantitative presentation of treatment
benefits are tested, our study supports presenting treat-
ment benefit information to patients as ARR or RRR, when
a baseline risk of disease is available, and verifying patient
understanding.
Our study does have several potential limitations. First,
written information on treatment benefits was presented
out of context in this study, reducing patients’ personal
involvement in the tasks measuring perception of treat-
ment benefit. Previous research has shown that the degree





 those who are highly involved process infor-
mation in a detailed and integrative way, whereas those who
are less involved process information superficially. Involving
patients in actual treatment decisions would be expected
to increase their processing of quantitative information,
although these effects may be diminished by the burden of
acute illness, which may make patients less able to process
complex information. Regardless, we expect that the out
of context presentation would affect all risk presentation
format groups equally.
Second, we asked subjects to interpret individual
benefit from NNT. This is not the task for which NNT was
proposed. This is, however, the task implied by those who
claim that NNT is easily understood by patients; patients
are intrinsically interested in how an intervention affects
them, not how an intervention affects the population from
which probabilistic information was derived.
Third, ARR, RRR, and NNT can be worded in many dif-
ferent ways. Whether alternate wording of the presentation
of treatment benefits would produce different results has
not been tested. In our study, the readability of treatment
benefits varied by risk reduction format (Fleisch-Kincade
grade levels 5.8 [RRR], 8.3 [ARR], 11.5 [NNT], and 10.9
[COMBO], despite the fact that the readability of the entire
presentation regarding treatment benefits was similar
(Fleisch-Kincade grade levels from 10.3 to 11.8). It may be
possible to word treatment benefit presentations so that
they are less different in reading grade levels. Future research
will help us determine what proportion of the difference in
patient understanding is from differences in the readability
of the presentations versus differences inherent to the
concepts themselves.
Fourth, we did not measure literacy. Inability to under-
stand the written presentations of treatment benefit and
the written questions (Fleisch-Kincade grade level 8) could
have accounted for some of our findings. Whether present-
ing the information orally would change results should be
investigated in future studies.
Fifth, subjects in this study had no opportunity to ask
questions about treatment benefits. It is possible simple
clarification from a physician may have significantly improved
patient understanding of some of these risk reduction formats.
Sixth, we used between-subject comparisons rather
than within-subject comparisons of the risk reduction
formats to reduce the length of the survey, increase the fea-
sibility of survey administration in our clinic setting, and
reduce “training” effects. Although within-subject compari-
sons have the advantage of allowing each subject to act
as his own control, we were able to study large numbers
of patients to minimize the effect of between-subject









of the persuasiveness of alternate risk reduction formats
in physicians have showed a high degree of consistency.
Seventh, our results may not be generalizable to patients
in other age groups. Older adults are more likely than middle-





Finally, the nonconsecutive nature of our sample
may also affect generalizability. When two eligible patients
presented to the clinic at the same time, our sole research
assistant could approach only one. We are not aware of appre-
ciable differences between the patients who were approached
to participate in the study and those who were not, but we
made no formal attempt to monitor differences. Similarly,
we do not have information on the patients who refused to
participate in our study. We suspect, however, that people
who did not participate were less confident in their quan-








Despite these limitations, this study provides impor-
tant information to clinicians who wish to help their patients
make informed decisions: many patients have poor numer-
acy skills; patients have difficulty interpreting quantitative
information; and NNT, and sometimes combination pre-
sentations, are interpreted less successfully than ARR or RRR.
To address patients’ limited ability to use quantitative
information, clinicians may, in the short term, want to use
written quantitative information only with patients with
higher numeracy skills; present information that uses com-
parison, not calculation; present risk reduction informa-
tion as ARR or RRR rather than as NNT or a combination
presentation; and verify patient understanding after the
presentation of treatment benefit information.
In the longer term, however, we believe researchers
should continue to explore the robustness of current obser-
vations on ARR, RRR, and NNT in different populations and
in different risk reduction scenarios, with alternate wording
and different combinations of ARR, RRR, and NNT. Both
clinicians and researchers should also work to improve
patient understanding of quantitative information through
exploring new presentation formats and developing patient
tutorials on how to interpret quantitative health information.
 
The authors thank David Ransohoff for his critical review of the
study methods; Mary Puckett for gathering data; Carol Porter
for data management; Joanne Garrett for statistical guidance;
Russell Harris, Donald Pathman, and fellows of the NRSA Primary
Care Research Program at the University of North Carolina for
their critical review of the manuscript; and Lisa Schwartz and
Steven Woloshin for their suggestions on the methods tables.
Financial support: Dr. Sheridan was supported by a
National Research Services Award (Public Health Service Grant
#PE 14001–14). Drs. Pignone and Lewis were supported by the
Lineberger Comprehensive Cancer Center and American





1. Institute of Medicine (US). Envisioning the National Health Care
Quality Report. Washington, DC: The Institute; 2001.
2. Rajkumar S, Sampathkumar P, Gustafson A. Number needed to
treat is a simple measure of treatment efficacy for clinicians. J Gen
Intern Med. 1996;11:357–9.
3. Schwartz LM, Woloshin S, Black WC, Welch HG. The role of numer-
acy in understanding the benefit of screening mammography. Ann
Intern Med. 1997;127:966–72.
4. Laupacis A, Sackett D, Roberts R. An assessment of clinically
useful measures of the consequences of treatment. N Engl J Med.
1988;318:1728–33.
5. Sackett D. Inference and decision at the bedside. J Clin Epidemiol.
1989;42:309–16.
6. Hutton JL. Number needed to treat: properties and problems.
J Royal Statist Soc A. 2000;163:403–19.
7. Hux JE, Naylor CD. Communicating the benefits of chronic pre-
ventive therapy: does the format of efficacy data determine patients’
acceptance of treatment? Med Decis Making. 1995;15:152–7.
8. Grimes DA, Snively GR. Patients’ understanding of medical risks:
implications for genetic counseling. Obstet Gynecol. 1999;93:910–
4.
9. Woloshin S, Schwartz L, Byram S, Fischhoff B, Welch H. A new
scale for assessing perceptions of chance: a validation study. Med
Decis Making. 2000;20:298–307.
10. Lipkus I, Samsa G, Rimer B. General performance on a numeracy
scale among highly educated samples. Med Decis Making. 2001;21:
37–44.
11. Woloshin S, Schwartz LM. How can we help people make sense of
medical data? Eff Clin Prac. 1999;2:176–83.
12. Feldman-Stewart D, Kocovski N, McConnell BA, Brundage MD,
Mackillop WJ. Perception of quantitative information for treatment
decisions. Med Decis Making. 2000;20:228–38.
13. McAlister F, Straus S, Guyatt G, Haynes RB. Users’ guide to the
medical literature XX. Integrating research evidence with the care
of the individual patient. J Am Med Assoc. 2000;283:2829–36.
14. Rothman A, Salovey P, Antone C, Keough K, Martin CD. The influ-
ence of message framing on intentions to perform health behaviors.
J Exp Social Psychol. 1993;29:408–33.
15. Bobbio M, Demichelis B, Giustetto G. Completeness of reporting
trial results: effect on physicians’ willingness to prescribe. Lancet.
1994;343:1209–11.
16. Cranney M, Walley T. Same information, different decisions: the
influence of evidence on the management of hypertension in the
elderly. Br J Gen Pract. 1996;46:661–3.
17. Forrow L, Taylor WC, Arnold RM. Absolutely relative: how research
results are summarized can affect treatment decisions. Am J Med.
1992;92:121–4.
18. Bucher HC, Weinbacher M, Gyr K. Influence of method of reporting
study results on decision of physicians to prescribe drugs to lower
cholesterol concentration. BMJ. 1994;309:761–4.
19. Naylor CD, Chen E, Strauss B. Measured enthusiasm: does the
method of reporting trial results alter perceptions of therapeutic
effectiveness? Ann Intern Med. 1992;117:916–21.
20. Nikolajevic-Sarunac J, Henry DA, O’Connell DL, Robertson J.
Effects of information framing on the intentions of family physicians
to prescribe long-term hormone replacement therapy. J Gen Intern
Med. 1999;14:591–8.
21. National Center for Education Statistics (US). Adult literacy in
America: a first look at the findings of the national adult literacy
survey. Washington, DC: US Department of Education; 1993.
